# NCT06498479 (NCT06498479)

> ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06498479
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Hansoh BioMedical R&D Company
- Conditions: Small Cell Lung Cancer
- Interventions: HS-20093; Topotecan
- Enrollment: 461
- Primary outcome: Overall survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct06498479